Reporting to the Vice President, Technical Operations, this leader will shape the future analytical operating model for Generate’s biologics portfolio, including analytical strategy, method lifecycle management, release and stability testing, specifications, comparability, external analytical operations, GMP readiness, and commercialization preparation across CDMO and contract testing partners. The Senior Director will serve as the senior analytical partner to CMC, Process Development, MS&T, Quality, Regulatory, Supply Chain, and external partners, ensuring protein therapeutics are supported by phase-appropriate, scientifically rigorous, inspection-ready analytical control strategies that advance key company objectives and enable late-stage development and commercialization readiness.